What is the CVSS score of CVE-2019-10968?

CVE-2019-10968 has a CVSS 3.1 base score of 4.4 (Medium). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N. EPSS exploitation probability: 0.3%.

Zymed Holter 2010 CVE-2019-10968

MEDIUM

Use of Obsolete Function (CWE-477)

2019-07-24 ics-cert@hq.dhs.gov

Information Disclosure Zymed Holter 2010

4.4

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

4.4 MEDIUM

AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N

Attack Vector

Local

Attack Complexity

Low

Privileges Required

High

User Interaction

None

Scope

Unchanged

Confidentiality

None

Integrity

High

Availability

None

Lifecycle Timeline

CVE Published

Jul 24, 2019 - 15:15 nvd

MEDIUM 4.4

DescriptionNVD

Philips Holter 2010 Plus, all versions. A vulnerability has been identified that may allow system options that were not purchased to be enabled.

AnalysisAI

Philips Holter 2010 Plus, all versions. Rated medium severity (CVSS 4.4), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-477. Philips Holter 2010 Plus, all versions. A vulnerability has been identified that may allow system options that were not purchased to be enabled. Affected products include: Philips Zymed Holter 2010.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.